MetLife Investment Management’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $552K | Buy |
|
|||||
|
2025
Q1 | $504K | Buy |
|
|||||
|
2024
Q4 | $926K | Buy |
|
|||||
|
2024
Q3 | $743K | Hold |
|
|||||
|
2024
Q2 | $685K | Buy |
|
|||||
|
2024
Q1 | $341K | Sell |
|
|||||
|
2023
Q4 | $114K | Hold |
|
|||||
|
2023
Q3 | $107K | Hold |
|
|||||
|
2023
Q2 | $126K | Hold |
|
|||||
|
2023
Q1 | $128K | Hold |
|
|||||
|
2022
Q4 | $140K | Hold |
|
|||||
|
2022
Q3 | $144K | Hold |
|
|||||
|
2022
Q2 | $130K | Hold |
|
|||||
|
2022
Q1 | $152K | Buy |
|
|||||
|
2021
Q4 | $105K | Hold |
|
|||||
|
2021
Q3 | $115K | Buy |
|